Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

Matthew J. Frigault; Binod Dhakal; Andrzej J. Jakubowiak; Noopur Raje; Kamalika Banerjee; C. Jenny Mu; Kevin C. Hart; Sigal Shachar; Lawrence Peter Andrews; Laurene S. Cheung; Faith M. Griffin; Alexandra R. Witter; Michael Hyde; Chester Pham; Nikitha Gandra; Tenzin Shakya; Bhargavi Rajan; Christa Cortesio; Samuel T. Haile; Heba Nowyhed; Priyanka Nair-Gupta; Priyam Mitra; Rebecca J. Chan; Ana Kostic; Christopher R. Heery; Jacalyn M. Rosenblatt; Michael Russell Bishop

doi:10.1056/nejmoa2603527

Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

Matthew J. Frigault, Binod Dhakal, Andrzej J. Jakubowiak, Noopur Raje, Kamalika Banerjee, C. Jenny Mu, Kevin C. Hart, Sigal Shachar, Lawrence Peter Andrews, Laurene S. Cheung, Faith M. Griffin, Alexandra R. Witter, Michael Hyde, Chester Pham, Nikitha Gandra, Tenzin Shakya, Bhargavi Rajan, Christa Cortesio, Samuel T. Haile, Heba Nowyhed, Priyanka Nair-Gupta, Priyam Mitra, Rebecca J. Chan, Ana Kostic, Christopher R. Heery, Jacalyn M. Rosenblatt, Michael Russell Bishop

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Esta revista no permite republicar el resumen completo. Estas son las dos oraciones que eligió Pipette, citadas textualmente. El resto está en el sitio de la editorial.

Resultado principal

CONCLUSIONS: Anito-cel therapy led to a high incidence of response among patients with heavily pretreated relapsed or refractory multiple myeloma.

Leer el paper

Apareció: viernes, 25 de septiembre. New England Journal of Medicine. Revista con revisión por pares.

DOI: 10.1056/nejmoa2603527

Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

En palabras de los autores

Más de Tratamiento del cáncer ese día

Neoadjuvant chemotherapy interferes with tertiary lymphoid structure formation in Epstein-Barr virus-associated gastric cancer

CXCL1-CXCR2 signaling mediates cancer cell growth and response to radiation therapy in leptomeningeal metastasis

SCRMP-mediated SUMOylation of CSNK2B facilitates DNA damage repair to promote cisplatin resistance in small cell lung cancer

Exploring the gut-brain axis in glioblastoma: a prospective case-control study of the gut bacteriome and mycobiome

CXCR6+ T cells are required for CD3xCD20 Bispecific Antibody Efficacy in B cell Lymphomas